+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A single center kidney transplant experience among ten Caucasian females with end-stage renal disease due to scleroderma




A single center kidney transplant experience among ten Caucasian females with end-stage renal disease due to scleroderma




Clinical Nephrology 88(1): 40-44



There is limited information on kidney transplant recipients with end-stage renal disease (ESRD) due to scleroderma. We conducted an observational study on kidney transplant recipients with ESRD due to scleroderma who received kidney transplant at our center between 01/1994 and 06/2013. During the study period, there were 10 kidney transplant recipients, all of whom were Caucasian females. Seven of them were living-donor kidney transplant recipients, and the mean age at time of transplant was 56.6 ± 11.99 years. The mean post-transplant follow-up was 76.75 ± 56.18 months; the mean dialysis vintage was 46.4 ± 80.35 months, ranging from 8 to 272 months; and the mean serum creatinine (Cr) levels at 3, 6, and 12 months were 1.31 ± 0.47 mg/dL, 1.35 ± 0.51 mg/dL, and 1.34 ± 0.49 mg/dL, respectively. There were 5 graft failures with median graft survival of 101 months. None had recurrence of scleroderma renal crisis. In those without graft failure, the mean serum Cr at last follow-up was 0.96 ± 0.39 mg/dL. Six patients were on angiotensin converting enzyme inhibitors (ACE-I) after transplant. In univariate analysis, none of the factors including, age at time of transplant, dialysis vintage, use of ACE-I, living-donor transplant, cytomegalovirus infection, and serum Cr at 1 year were predictive of graft failure. In our study, we hoped to find outcomes and various factors associated with graft failure in these patients. We found a wide variation in outcomes after kidney transplantation. More studies are needed to assess the factors that may influence the graft survival in this rare disease.
.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059405046

Download citation: RISBibTeXText

PMID: 28406085


Related references

Kidney transplantation for end-stage renal disease in lupus nephritis, a very safe procedure: a single Latin American transplant center experience. Lupus 26(11): 1157-1165, 2017

Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease. Therapeutic Apheresis and Dialysis 17(4): 363-367, 2013

End-stage renal disease after kidney donation: a single-center experience. Transplantation Proceedings 40(5): 1315-1318, 2008

End-stage renal disease among living-kidney donors: single-center experience. Experimental and Clinical Transplantation 9(1): 14-19, 2011

Kidney transplantation alone in end-stage renal disease patients with hepatitis B liver cirrhosis: a single-center experience. Transplantation 99(1): 133-138, 2015

Kidney Transplantation in Korean Patients With End-Stage Renal Disease Aged 65 and Older: A Single-Center Experience. Transplantation Proceedings 49(5): 987-991, 2017

Pre-liver transplant renal dysfunction and association with post-transplant end-stage renal disease: A single-center examination of updated UNOS recommendations. Clinical Transplantation 32(12): E13428, 2018

Autosomal Dominant Polycystic Kidney Disease Transplant Recipients After Kidney Transplantation: A Single-center Experience. Transplantation Proceedings 49(7): 1522-1525, 2017

Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephron. Clinical Practice 109(3): C109-C118, 2008

Survival and Evolution of Renal Function in Kidney Transplant Recipients From Type II Asystolic Donations: A Single-center Experience. Transplantation Proceedings 50(2): 565-568, 2018

Cytomegalovirus disease in renal transplant recipients: a single-center experience. Indian Journal of Microbiology 52(3): 510-515, 2012

Cytomegalovirus disease in renal transplant recipients: a single-center experience. Renal Failure 30(5): 503-506, 2008

Cytomegalovirus disease in renal transplant recipients: a single-center experience. Experimental and Clinical Transplantation 5(1): 601-603, 2007

Long-term outcome in kidney transplant recipients over 70 years in the Eurotransplant Senior Kidney Transplant Program: a single center experience. Transplantation 92(2): 210-216, 2011

Outcomes of renal transplantation after end-stage renal disease due to diabetic nephropathy: a single-center experience. Transplantation Proceedings 44(1): 77-79, 2012